Mechanisms of NLRP3 inflammasome activation and the development of peptide inhibitors
出版年份 2023 全文链接
标题
Mechanisms of NLRP3 inflammasome activation and the development of peptide inhibitors
作者
关键词
-
出版物
CYTOKINE & GROWTH FACTOR REVIEWS
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-10-01
DOI
10.1016/j.cytogfr.2023.09.007
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pharmacological Inhibition of the NLRP3 Inflammasome: Structure, Molecular Activation, and Inhibitor-NLRP3 Interaction
- (2023) Qiang Ma PHARMACOLOGICAL REVIEWS
- Structural Mechanisms of NLRP3 Inflammasome Assembly and Activation
- (2023) Jianing Fu et al. Annual Review of Immunology
- Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review)
- (2023) Xiaolu Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets
- (2023) Daniela Maria Tanase et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NLRP3 inflammasome activation, metabolic danger signals, and protein binding partners
- (2023) Sy-Ying Leu et al. JOURNAL OF ENDOCRINOLOGY
- Regulation of the NLRP3 Inflammasome by Posttranslational Modifications
- (2022) Safoura Zangiabadi et al. JOURNAL OF IMMUNOLOGY
- Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3
- (2022) Inga V. Hochheiser et al. NATURE
- Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective
- (2022) Yongsheng Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson’s disease
- (2022) Nikhil Panicker et al. NEURON
- NLRP3 and pyroptosis blockers for treating inflammatory diseases
- (2022) Rebecca C. Coll et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Directionality of PYD filament growth determined by the transition of NLRP3 nucleation seeds to ASC elongation
- (2022) Inga V. Hochheiser et al. Science Advances
- Mitochondria and the NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis
- (2022) Sandra Torres et al. Cells
- The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases
- (2022) Hallie M. Blevins et al. Frontiers in Aging Neuroscience
- Role of NLRP3 Inflammasome in Rheumatoid Arthritis
- (2022) Hui Yin et al. Frontiers in Immunology
- Morroniside alleviates lipopolysaccharide-induced inflammatory and oxidative stress in inflammatory bowel disease by inhibiting NLRP3 and NF-κB signaling pathways
- (2022) Shifen Zhang et al. ALLERGOLOGIA ET IMMUNOPATHOLOGIA
- The inflammasome in biomaterial‐driven immunomodulation
- (2022) Daniela P. Vasconcelos et al. Journal of Tissue Engineering and Regenerative Medicine
- The AIM2 Inflammasome: A Novel Biomarker and Target in Cardiovascular Disease
- (2022) Luping Du et al. PHARMACOLOGICAL RESEARCH
- NLRP3 inflammasome and NLRP3-related autoinflammatory diseases: From cryopyrin function to targeted therapies
- (2022) Chiara Moltrasio et al. Frontiers in Immunology
- NLRP3 inflammasome in digestive diseases: From mechanism to therapy
- (2022) Rui Qiang et al. Frontiers in Immunology
- ATP-binding and hydrolysis of human NLRP3
- (2022) Rebecca Brinkschulte et al. Communications Biology
- NLRP3 inflammasome: The rising star in cardiovascular diseases
- (2022) Yidan Zheng et al. Frontiers in Cardiovascular Medicine
- The NLRP3 inflammasome in depression: Potential mechanisms and therapies
- (2022) Cong-Yuan Xia et al. PHARMACOLOGICAL RESEARCH
- Trends in peptide drug discovery
- (2021) Markus Muttenthaler et al. NATURE REVIEWS DRUG DISCOVERY
- Acinar cell NLRP3 inflammasome and GSDMD activation mediates pyroptosis and systemic inflammation in acute pancreatitis
- (2021) Lin Gao et al. BRITISH JOURNAL OF PHARMACOLOGY
- An update on the regulatory mechanisms of NLRP3 inflammasome activation
- (2021) Seungwha Paik et al. Cellular & Molecular Immunology
- Non-alcoholic fatty liver disease
- (2021) Elizabeth E Powell et al. LANCET
- Gasdermin D in pyroptosis
- (2021) Brandon Burdette et al. Acta Pharmaceutica Sinica B
- Structures and functions of the inflammasome engine
- (2021) Longfei Wang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- NLRP3 inflammasome and IL-1β pathway in type 2 diabetes and atherosclerosis: friend or foe?
- (2021) Xu Chen et al. PHARMACOLOGICAL RESEARCH
- Sensing low intracellular potassium by NLRP3 results in a stable open structure that promotes inflammasome activation
- (2021) Ana Tapia-Abellán et al. Science Advances
- Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7‐NLRP3 interaction
- (2021) Qiang Li et al. EMBO REPORTS
- GPA Peptide Attenuates Sepsis-Induced Acute Lung Injury in Mice via Inhibiting Oxidative Stress and Pyroptosis of Alveolar Macrophage
- (2021) Yukun Liu et al. Oxidative Medicine and Cellular Longevity
- A long way to go: caspase inhibitors in clinical use
- (2021) Shanel Dhani et al. Cell Death & Disease
- NLRP3 inflammasome activation triggers gasdermin D–independent inflammation
- (2021) Chun Wang et al. Science Immunology
- Targeting the NLRP3 inflammasome in cardiovascular diseases
- (2021) Stefano Toldo et al. PHARMACOLOGY & THERAPEUTICS
- An Acetylation Switch of the NLRP3 Inflammasome Regulates Aging-Associated Chronic Inflammation and Insulin Resistance
- (2020) Ming He et al. Cell Metabolism
- Erythropoietin and its derivatives: from tissue protection to immune regulation
- (2020) Bo Peng et al. Cell Death & Disease
- NEK7: a potential therapy target for NLRP3-related diseases
- (2020) Ganglei Liu et al. BioScience Trends
- Inhibition of TLR4 Induces M2 Microglial Polarization and Provides Neuroprotection via the NLRP3 Inflammasome in Alzheimer’s Disease
- (2020) Weigang Cui et al. Frontiers in Neuroscience
- Selective inhibition of NLRP3 inflammasome by designed peptide originating from ASC
- (2020) Petra Sušjan et al. FASEB JOURNAL
- Genetic analysis of nucleotide-binding leucine-rich repeat (NLR) receptors in multiple sclerosis
- (2020) Lisa F. Popplewell et al. IMMUNOGENETICS
- Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors
- (2020) Ni Zhao et al. JOURNAL OF AUTOIMMUNITY
- Research Development and Optimization Modifications of Anti-cancer peptides
- (2020) Zhi-Gang Sun et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- GPA peptide inhibits NLRP3 inflammasome activation to ameliorate colitis through AMPK pathway
- (2020) Zhao Deng et al. Aging-US
- GPA peptide enhances Nur77 expression in intestinal epithelial cells to exert a protective effect against DSS‐induced colitis
- (2020) Zhao Deng et al. FASEB JOURNAL
- The NLRP3 inflammasome: Mechanism of action, role in disease and therapies
- (2020) Li Wang et al. MOLECULAR ASPECTS OF MEDICINE
- Detection of Viral Infections by Innate Immunity
- (2020) Michael Carty et al. BIOCHEMICAL PHARMACOLOGY
- NIMA-related kinase 7 amplifies NLRP3 inflammasome pro-inflammatory signaling in microglia/macrophages and mice models of spinal cord injury
- (2020) Xubiao Ji et al. EXPERIMENTAL CELL RESEARCH
- An overview of the non-canonical inflammasome
- (2020) Kevin P. Downs et al. MOLECULAR ASPECTS OF MEDICINE
- Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome
- (2019) Zhilei Wang et al. Acta Pharmaceutica Sinica B
- Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
- (2019) Yang Yang et al. Cell Death & Disease
- ABRO1 promotes NLRP3 inflammasome activation through regulation of NLRP3 deubiquitination
- (2019) Guangming Ren et al. EMBO JOURNAL
- Effects of phosphorylation on the NLRP3 inflammasome
- (2019) Christina F. Sandall et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- A Comprehensive Review on Current Advances in Peptide Drug Development and Design
- (2019) Andy Chi-Lung Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CAPS and NLRP3
- (2019) Laela M. Booshehri et al. JOURNAL OF CLINICAL IMMUNOLOGY
- MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
- (2019) Rebecca C. Coll et al. Nature Chemical Biology
- Caspases in Cell Death, Inflammation, and Disease
- (2019) Nina Van Opdenbosch et al. IMMUNITY
- Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome
- (2019) Humayun Sharif et al. NATURE
- Dulaglutide inhibits high glucose- induced endothelial dysfunction and NLRP3 inflammasome activation
- (2019) Xiaojia Luo et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Emerging Activators and Regulators of Inflammasomes and Pyroptosis
- (2019) Yansong Xue et al. TRENDS IN IMMUNOLOGY
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2019) Søren L Kristensen et al. Lancet Diabetes & Endocrinology
- Vasoactive intestinal peptide suppresses the NLRP3 inflammasome activation in lipopolysaccharide-induced acute lung injury mice and macrophages
- (2019) Yong Zhou et al. BIOMEDICINE & PHARMACOTHERAPY
- Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy
- (2019) Xinyang Yu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- SUMO1 SUMOylates and SENP3 deSUMOylates NLRP3 to orchestrate the inflammasome activation
- (2019) Luyao Shao et al. FASEB JOURNAL
- Mitochondria, the NLRP3 Inflammasome, and Sirtuins in Type 2 Diabetes: New Therapeutic Targets
- (2018) Susana Rovira-Llopis et al. ANTIOXIDANTS & REDOX SIGNALING
- Liraglutide attenuates NLRP3 inflammasome-dependent pyroptosis via regulating SIRT1/NOX4/ROS pathway in H9c2 cells
- (2018) Ao Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tranilast directly targets NLRP3 to treat inflammasome‐driven diseases
- (2018) Yi Huang et al. EMBO Molecular Medicine
- Structural insights into pharmacophore-assisted in silico identification of protein–protein interaction inhibitors for inhibition of human toll-like receptor 4 – myeloid differentiation factor-2 (hTLR4−MD-2) complex
- (2018) Vinita Mishra et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Curcumin Suppresses IL-1β Secretion and Prevents Inflammation through Inhibition of the NLRP3 Inflammasome
- (2018) Haipeng Yin et al. JOURNAL OF IMMUNOLOGY
- Vasoactive intestinal peptide overexpression mediated by lentivirus attenuates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation
- (2018) Guo-Ying Sun et al. MOLECULAR IMMUNOLOGY
- Mechanism of gasdermin D recognition by inflammatory caspases and their inhibition by a gasdermin D-derived peptide inhibitor
- (2018) Jie Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
- (2018) Carlo Marchetti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity
- (2018) Hongbin He et al. Nature Communications
- The oxidized phospholipid oxPAPC protects from septic shock by targeting the non-canonical inflammasome in macrophages
- (2018) Lan H. Chu et al. Nature Communications
- NLRP3: A Novel Mediator in Cardiovascular Disease
- (2018) Wenyi Zhou et al. Journal of Immunology Research
- The Neuropeptides Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Control HIV-1 Infection in Macrophages Through Activation of Protein Kinases A and C
- (2018) Jairo R. Temerozo et al. Frontiers in Immunology
- Cryo-EM structure of the gasdermin A3 membrane pore
- (2018) Jianbin Ruan et al. NATURE
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- SUMO-mediated regulation of NLRP3 modulates inflammasome activity
- (2018) Rachael Barry et al. Nature Communications
- Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice
- (2018) Richard Gordon et al. Science Translational Medicine
- NLRP3 lacking the leucine-rich repeat domain can be fully activated via the canonical inflammasome pathway
- (2018) Iva Hafner-Bratkovič et al. Nature Communications
- The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease
- (2018) Shuo Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
- (2017) Hua Jiang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway
- (2017) Yang Zhao et al. Molecular Cancer
- NLRP3 Phosphorylation Is an Essential Priming Event for Inflammasome Activation
- (2017) Nan Song et al. MOLECULAR CELL
- Sirt1 Inhibits Oxidative Stress in Vascular Endothelial Cells
- (2017) Weijin Zhang et al. Oxidative Medicine and Cellular Longevity
- Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in Major depressive disorder
- (2017) Elísabet Alcocer-Gómez et al. PHARMACOLOGICAL RESEARCH
- AMPK Maintains Cellular Metabolic Homeostasis through Regulation of Mitochondrial Reactive Oxygen Species
- (2017) Rebecca C. Rabinovitch et al. Cell Reports
- NEK7: a novel promising therapy target for NLRP3-related inflammatory diseases
- (2016) Jin Xu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Bacterial Outer Membrane Vesicles Mediate Cytosolic Localization of LPS and Caspase-11 Activation
- (2016) Sivapriya Kailasan Vanaja et al. CELL
- Human Monocytes Engage an Alternative Inflammasome Pathway
- (2016) Moritz M. Gaidt et al. IMMUNITY
- The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation
- (2016) Deepika Sharma et al. JOURNAL OF CELL BIOLOGY
- Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
- (2016) Xing Liu et al. NATURE
- Molecular basis of caspase-1 polymerization and its inhibition by a new capping mechanism
- (2016) Alvin Lu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The effects of vasoactive intestinal peptide in neurodegenerative disorders
- (2016) Guangxiu Deng et al. NEUROLOGICAL RESEARCH
- Molecular basis of caspase-1 polymerization and its inhibition by a new capping mechanism
- (2016) Alvin Lu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structure-Based Design of Inhibitors of Protein-Protein Interactions: Mimicking Peptide Binding Epitopes
- (2015) Marta Pelay-Gimeno et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Modulating protein–protein interactions: the potential of peptides
- (2015) Laura Nevola et al. CHEMICAL COMMUNICATIONS
- Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients
- (2015) Altaf Afrasyab et al. HEART AND VESSELS
- The NLRP1 inflammasomes
- (2015) Joseph Chavarría-Smith et al. IMMUNOLOGICAL REVIEWS
- P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation
- (2015) KUANG PENG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Toll-like receptor 4-interacting SPA4 peptide suppresses the NLRP3 inflammasome in response to LPS and ATP stimuli
- (2015) Vijay Ramani et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease
- (2015) Yun-Hee Youm et al. NATURE MEDICINE
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Inflammasomes: mechanism of action, role in disease and therapeutics
- (2015) Haitao Guo et al. NATURE MEDICINE
- A novel proteolysis-resistant cyclic helix B peptide ameliorates kidney ischemia reperfusion injury
- (2014) Cheng Yang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Inflammatory caspases are innate immune receptors for intracellular LPS
- (2014) Jianjin Shi et al. NATURE
- Nitric oxide suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock
- (2013) Kairui Mao et al. CELL RESEARCH
- Involvement of Inflammasome Activation in Lipopolysaccharide-induced Mice Depressive-like Behaviors
- (2013) Yi Zhang et al. CNS Neuroscience & Therapeutics
- NLRP3 Inflammasomes Show High Expression in Aorta of Patients with Atherosclerosis
- (2013) Fei Zheng et al. Heart Lung and Circulation
- Mitochondrial Cardiolipin Is Required for Nlrp3 Inflammasome Activation
- (2013) Shankar S. Iyer et al. IMMUNITY
- A TLR4-interacting SPA4 peptide inhibits LPS-induced lung inflammation
- (2013) Vijay Ramani et al. Innate Immunity
- Crystal Structure of NLRC4 Reveals Its Autoinhibition Mechanism
- (2013) Z. Hu et al. SCIENCE
- Cytoplasmic LPS Activates Caspase-11: Implications in TLR4-Independent Endotoxic Shock
- (2013) J. A. Hagar et al. SCIENCE
- Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4
- (2013) N. Kayagaki et al. SCIENCE
- NLR activation takes a direct route
- (2013) Tom P. Monie TRENDS IN BIOCHEMICAL SCIENCES
- Research progress on the NLRP3 inflammasome and its role in the central nervous system
- (2013) Shen-Bin Liu et al. Neuroscience Bulletin
- High expression of arachidonate 15-lipoxygenase and proinflammatory markers in human ischemic heart tissue
- (2012) Lisa U. Magnusson et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Reduced expression of NLRP3 and MEFV in human ischemic heart tissue
- (2012) Cecilia Hermansson et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Future of Peptide-based Drugs
- (2012) David J. Craik et al. Chemical Biology & Drug Design
- Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
- (2012) Hye-Mi Lee et al. DIABETES
- Structures of the HIN Domain:DNA Complexes Reveal Ligand Binding and Activation Mechanisms of the AIM2 Inflammasome and IFI16 Receptor
- (2012) Tengchuan Jin et al. IMMUNITY
- PAMPs and DAMPs: signal 0s that spur autophagy and immunity
- (2012) Daolin Tang et al. IMMUNOLOGICAL REVIEWS
- TLR Agonists Stimulate Nlrp3-Dependent IL-1 Production Independently of the Purinergic P2X7 Receptor in Dendritic Cells and In Vivo
- (2012) Y. He et al. JOURNAL OF IMMUNOLOGY
- A TLR4-interacting peptide inhibits lipopolysaccharide-stimulated inflammatory responses, migration and invasion of colon cancer SW480 cells
- (2012) Madhusoodhanan Rakhesh et al. OncoImmunology
- Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury
- (2011) Masanori Kawaguchi et al. CIRCULATION
- Crystal Structure of NALP3 Protein Pyrin Domain (PYD) and Its Implications in Inflammasome Assembly
- (2011) Ju Young Bae et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Non-canonical inflammasome activation targets caspase-11
- (2011) Nobuhiko Kayagaki et al. NATURE
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
- (2011) Bolormaa Vandanmagsar et al. NATURE MEDICINE
- A Toll-Like Receptor-4-Interacting Surfactant Protein-A-Derived Peptide Suppresses Tumor Necrosis Factor- Release from Mouse JAWS II Dendritic Cells
- (2010) S. Awasthi et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation
- (2010) Kristiina Rajamäki et al. PLoS One
- Altered redox state of monocytes from cryopyrin-associated periodic syndromes causes accelerated IL-1 secretion
- (2010) S. Tassi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Patterns of Pathogenesis: Discrimination of Pathogenic and Nonpathogenic Microbes by the Innate Immune System
- (2009) Russell E. Vance et al. Cell Host & Microbe
- Cutting Edge: TNF- Mediates Sensitization to ATP and Silica via the NLRP3 Inflammasome in the Absence of Microbial Stimulation
- (2009) L. Franchi et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: NF- B Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
- (2009) F. G. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
- Molecular mechanisms involved in inflammasome activation
- (2009) Clare Bryant et al. TRENDS IN CELL BIOLOGY
- Protein therapeutics: a summary and pharmacological classification
- (2007) Benjamin Leader et al. NATURE REVIEWS DRUG DISCOVERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now